bay x 1005 has been researched along with Edema in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahr, HJ; Beckermann, B; Bühner, K; Fruchtmann, R; Kohlsdorfer, C; Mohrs, KH; Müller-Peddinghaus, R; Perzborn, E; Theisen-Popp, P | 1 |
Burchardt, ER; Müller-Peddinghaus, R | 2 |
3 other study(ies) available for bay x 1005 and Edema
Article | Year |
---|---|
BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
Topics: Animals; Biological Assay; Edema; Female; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Pleurisy; Protein Binding; Quinolines; Rats | 1993 |
Antiedematous effects of combination therapies with the leukotriene synthesis inhibitor BAY X 1005 in the archidonic acid-induced mouse ear inflammation test.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Disease Models, Animal; Drug Therapy, Combination; Ear; Edema; Female; Histamine H1 Antagonists; Indomethacin; Inflammation; Lipoxygenase Inhibitors; Methysergide; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrilamine; Quinolines; Serotonin Antagonists | 1997 |
Favorable combination effects of the leukotriene synthesis inhibitor BAY X 1005 and dexamethasone on edema formation in the arachidonic acid-induced mouse ear inflammation test.
Topics: Animals; Arachidonic Acid; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Edema; Female; Inflammation; Lipoxygenase Inhibitors; Mice; Quinolines | 1999 |